Nanoemulsion formulation containing carbamazepine and levetiracetam: Development and in vitro characterization

Abstract

Background and Aims: Epilepsy is one of the most disabling and most common neurological disorders, affecting approximately 65 million people of all age groups worldwide. When there is no response to monotherapy in the treatment of epilepsy, the combined use of Carbamazepine (CARBA) and Levetiracetam (LEV), which have different mechanisms of action, can be additive/synergistic and may be useful in the clinic. The aim of our study is to develop a fixed-dose combination (FDC)- nanoemulsion (NE) formulation containing CARBA and LEV for the treatment of epilepsy. Methods: Blank NE (BLNK-NE) and CARBA+LEV-FDC-NE formulations were prepared and carried out the in vitro characterization studies [morphological analysis, centrifugation test, droplet size (DS), polydispersity index (PDI), zeta potential (ZP), viscosity and pH measurements, FT-IR analysis, the percent entrapment efficiency (EE%), and in vitro release study]. Results: The DS, PDI, pH, and ZP values for the BLNK-NE formulation were found to be 117.63±3.82 nm, 0.240±0.014, 4.62±0.03, and (-)26.07±3.04 mV, respectively. For the CARBA+LEV-FDC-NE formulation, the DS, PDI, pH, and ZP values were determined as 137.56±3.11 nm, 0.225±0.013, 4.60±0.06, and (-)21.62±0.29 mV, respectively. The EE% values obtained for CARBA+LEV-FDC-NE were 97.33±0.56% (for CARBA) and 96.73±0.91% (for LEV). Conclusion: The CARBA+LEV-FDC-NE formulation was successfully prepared. This formulation had suitable in vitro characterization results.

Keywords

• Carbamazepine
• epilepsy
• fixed-dose combination
• levetiracetam
• nanoemulsion

References

1. Alkhatib, M.H., Bawadud, R.S., & Gashlan, H.M. (2020). Incorpora-tion of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells. Scientific Reports, 10(1), 18124. doi:10.1038/s41598-020-75017-5 google scholar
2. Alkreathy, H., Alkhatib, M., Al-thepyani, M., Balamash, K., Alghamdi, S., Karim, S., & Ahmad, A. (2020). Synergistic antitumor activity of doxorubicin and atorvastatin combination loaded nanoemulsion in mice. International Journal of Pharmacology, 16(4), 330-342. doi:10.3923/ijp.2020.330.342 google scholar
3. Beydoun, A., DuPont, S., Zhou, D., Matta, M., Nagire, V., & Lagae, L. (2020). Current role of carbamazepine and oxcarbazepine in the management of epilepsy. Seizure, 83, 251-263. doi:10.1016/j. seizure.2020.10.018 google scholar
4. Devinsky, O., Vezzani, A., O’Brien, T.J., Jette, N., Scheffer, I.E., de Cur-tis, M., & Perucca, P. (2018). Epilepsy. Nature Reviews Disease Prim-ers, 4(1), 1-24. doi:10.1038/nrdp.2018.24 google scholar
5. Djekic, L., Markovic, B., Micov, A., Tomic, M., Pecikoza, U., & Stepanovic-Petrovic, R. (2021). Percutaneous delivery of leve-tiracetam as an alternative to topical nonsteroidal anti-inflam-matory drugs: formulation development, in vitro and in vivo characterization. Drug Delivery and Translational Research, 11(1), 227-241. doi:10.1007/s13346-020-00787-4 google scholar
6. Echeverri, J.D., Alhajj, M.J., Montero, N., Yarce, C.J., Barrera-Ocampo, A., & Salamanca, C. H. (2020). Study of In Vitro and In Vivo Carbam-azepine Release from Coarse and Nanometric Pharmaceutical Emul-sions Obtained via Ultra-High-Pressure Homogenization. Pharma-ceuticals (Basel, Switzerland), 13(4), E53. doi:10.3390/ph13040053 google scholar
7. Ensom, M.H.H., Decarie, D., & Rudolph, S. (2011). Stability of le-vetiracetam in extemporaneously compounded suspensions. The Canadian Journal of Hospital Pharmacy, 64(3), 207-211. doi:10.4212/cjhp.v64i3.1024. google scholar
8. Green, S.F., Nguyen, P., Kaalund-Hansen, K., Rajakulendran, S., & Murphy, E. (2020). Effectiveness, retention, and safety of modified ketogenic diet in adults with epilepsy at a tertiary-care centre in the UK. Journal of Neurology, 267(4), 1171-1178. doi:10.1007/ s00415-019-09658-6 google scholar

9. Gupta, A. (2020). Chapter 21 - Nanoemulsions. In E. J. Chung, L. Leon, & C. Rinaldi (Eds.), Nanoparticles for Biomedical Applications (pp. 371-384). Elsevier. doi:10.1016/B978-0-12-816662-8.00021-7 google scholar
10. Hu, M., Xie, F., Zhang, S., Qi, B., & Li, Y. (2021). Effect of nanoemul-sion particle size on the bioavailability and bioactivity of perilla oil in rats. Journal of Food Science, 86(1), 206-214. doi:10.1111/1750-3841.15537 google scholar
11. Kandilli, B., Uğur, A.B., Çetin, M., & Miloğlu, F.D. (2018). A simple HPLC-UV method for simultaneous determination of levetirace-tam and carbamazepine, Hacettepe University Journal of the Fac-ulty of Pharmacy, 38(2), 58-64. google scholar
12. Kandilli, B., Ugur Kaplan, A.B., Cetin, M., Taspinar, N., Ertugrul, M.S., Aydin, I.C., & Hacimuftuoglu, A. (2020). Carbamazepine and leveti-racetam-loaded PLGA nanoparticles prepared by nanoprecipitation method: in vitro and in vivo studies. Drug Development and Industrial Pharmacy, 46(7), 1063-1072. doi:10.1080/03639045.2020.1769127 google scholar
13. Kanner, A.M., & Bicchi, M. M. (2022). Antiseizure medications for adults with epilepsy: A Review. JAMA, 327(13), 1269-1281. doi:10.1001/jama.2022.3880 google scholar
14. Kelmann, R.G., Kuminek, G., Teixeira, H.F., & Koester, L.S. (2007). Carbamazepine parenteral nanoemulsions prepared by sponta-neous emulsification process. International Journal of Pharmaceu-tics, 342(1-2), 231-239. doi:10.1016/j.ijpharm.2007.05.004 google scholar
15. Kim, D.W., & Weon, K.Y. (2021). Pharmaceutical application and de-velopment of fixed-dose combination: dosage form review. Jour-nal of Pharmaceutical Investigation, 51(5), 555-570. doi:10.1007/ s40005-021-00543-x google scholar
16. Kumar, A., Maini, K., & Kadian, R. (2022). Levetiracetam. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Retrived from https://www.ncbi.nlm.nih.gov/books/NBK499890/ google scholar
17. Lovelyn, C., & Attama, A.A. (2011). Current state of nanoemulsions in drug delivery. Journal of Biomaterials and Nanobiotechnology, 02(05), 626. doi:10.4236/jbnb.2011.225075 google scholar
18. Lyseng-Williamson, K.A. (2011). Levetiracetam: a review of its use in epilepsy. Drugs, 71(4), 489-514. doi:10.2165/11204490-000000000-00000 google scholar
19. Maan, J. S., Duong, T. vi H., & Saadabadi, A. (2022). Carbamazepine. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Retrived from https://www.ncbi.nlm.nih.gov/books/NBK482455/ google scholar
20. Mahajan, H.S., & Patil, N.D. (2021). Nanoemulsion containing a synergistic combination of curcumin and quercetin for nose-to-brain delivery: In vitro and in vivo studies. Asian Pacific Journal of Tropical Biomedicine, 11(11), 510. doi:10.4103/2221-1691.328058 google scholar
21. Mahamat Nor, S.B., Woi, P.M., & Ng, S.H. (2017). Characterisation of ionic liquids nanoemulsion loaded with piroxicam for drug deliv-ery system. Journal of Molecular Liquids, 234, 30-39. doi:10.1016/j. molliq.2017.03.042 google scholar
22. Makinen, J., Rainesalo, S., Raitanen, J., & Peltola, J. (2017). The effect of newer antiepileptic drugs in combination therapy. Epilepsy Re-search, 132, 15-20. doi:10.1016/j.eplepsyres.2017.02.020 google scholar
23. Nastiti, C.M.R R., Ponto, T., Abd, E., Grice, J.E., Benson, H.A.E., & Rob-erts, M.S. (2017). Topical nano and microemulsions for skin deliv-ery. Pharmaceutics, 9(4), E37. doi:10.3390/pharmaceutics9040037 google scholar
24. Pangeni, R., Choi, S.W., Jeon, O.C., Byun, Y., & Park, J.W. (2016). Multiple nanoemulsion system for an oral combinational de-livery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation. International Journal of Nanomedicine, 11, 6379-6399. doi:10.2147/IJN.S121114 google scholar
25. Park, K.M., Kim, S.E., & Lee, B.I. (2019). Antiepileptic drug therapy in patients with drug-resistant epilepsy. Journal of Epilepsy Research, 9(1), 14-26. doi:10.14581/jer.19002 google scholar
26. Patel, R.J., & Parikh, R.H. (2020). Intranasal delivery of topiramate nanoemulsion: Pharmacodynamic, pharmacokinetic and brain uptake studies. International Journal of Pharmaceutics, 585, 119486. doi:10.1016/j.ijpharm.2020.119486 google scholar
27. Petrusevska, M., Berglez, S., Krisch, I., Legen, I., Megusar, K., Peter-nel, L.,... Dressman, J. (2015). Biowaiver monographs for immedi-ate release solid oral dosage forms: levetiracetam. Journal of Phar-maceutical Sciences, 104(9), 2676-2687. doi:10.1002/jps.24350 google scholar
28. Prokhorov, D.I., Sariev, A. K., Abramov, D.A., Voronina, T.A., Kapitsa, I.G., Zhuravko, A.S., . Seifulla, R.D. (2014). Experimental investiga-tion of pharmacodynamics and pharmacokinetics of carbamaze-pine nanoemulsion. Bulletin of Experimental Biology and Medicine, 157(6), 742-746. doi:10.1007/s10517-014-2657-z google scholar
29. Rahman, M., Islam, F., Rahman, A., Ahmed, T., Uddin, M.B., Sha-heen, S.M., & Khushi, S.Y. (2020). Present and future prospect of combination drugs therapy. World Journal of Pharmaceutical Re-search, 9(3), 1625-1638. google scholar
30. Rajadhyaksha, N.S., Jain, S.P., & Amin, P.D. (2007). Carbamazepine: Stability indicating HPLC assay method. Analytical Letters, 40(13), 2506-2514. doi:10.1080/00032710701583557 google scholar
31. Rehman, A.U., Akram, S., Seralin, A., Vandamme, T., & Anton, N. (2020). Chapter 21 - Lipid nanocarriers: Formulation, properties, and applications. In P. Nguyen-Tri, T.-O. Do, & T. A. Nguyen (Eds.), Smart Nanocontainers (pp. 355-382). Elsevier. doi:10.1016/B978-0-12-816770-0.00021-6 google scholar
32. Rosso, A., Lollo, G., Chevalier, Y., Troung, N., Bordes, C., Bourgeois, S., . Briançon, S. (2020). Development and structural character-ization of a novel nanoemulsion for oral drug delivery. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 593, 124614. doi:10.1016/j.colsurfa.2020.124614 google scholar
33. Sabjan, K.B., Munawar, S.M., Rajendiran, D., Vinoji, S.K., & Kasina-than, K. (2020). Nanoemulsion as oral drug delivery - a review. Current Drug Research Reviews, 12(1), 4-15. google scholar
34. Santos, J.,Trujillo-Cayado, L.A., Carrillo, F., Lopez-Castejon, M. L., & Alfaro-Rodrfguez, M. C. (2022). Relation between droplet size dis-tributions and physical stability for zein microfluidized emulsions. Polymers, 14(11), 2195. doi:10.3390/polym14112195 google scholar
35. Sarhan, E.M., Walker, M.C., & Selai, C. (2016). Evidence for efficacy of combination of antiepileptic drugs in treatment of epilepsy. Jour-nal of Neurology Research, 5(6), 267-276. doi:10.14740/jnr.v5i6.356 google scholar
36. Sigward, E., Mignet, N., Rat, P., Dutot, M., Muhamed, S., Guigner, J.-M., . Crauste-Manciet, S. (2013). Formulation and cytotoxic-ity evaluation of new self-emulsifying multiple W/O/W nano-emulsions. International Journal of Nanomedicine, 8, 611-625. doi:10.2147/IJN.S35661 google scholar
37. Ugur Kaplan, A.B., Cetin, M., Orgul, D., Taghizadehghalehjoughi, A., Hacımuftuoglu, A., & Hekimoglu, S. (2019). Formulation and in vitro evaluation of topical nanoemulsion and nanoemulsion-based gels containing daidzein. Journal of Drug Delivery Science and Technology, 52, 189-203. doi:10.1016/j.jddst.2019.04.027 google scholar
38. Uzunovic, A., Vranic, E., & Hadzidedic, S. (2010). Impairment of the in vitro release of carbamazepine from tablets. Bosnian Journal of Basic Medical Sciences, 10(3), 234-238. google scholar
39. Vazquez-Blanco, S., Gonzalez-Freire, L., Davila-Pousa, M. C., & Cre-spo-Diz, C. (2018). pH determination as a quality standard for the elaboration of oral liquid compounding formula. Farmacia Hospi-talaria: Organo Oficial De Expresion Cientifica De La Sociedad Espa-nola De Farmacia Hospitalaria, 42(6), 221-227. doi:10.7399/fh.10932 google scholar
40. Wik, J., Bansal, K.K., Assmuth, T., Rosling, A, Rosenholm, J.M. (2020). Facile methodology of nanoemulsion preparation using oily poly-mer for the delivery of poorly soluble drugs. Drug Delivery and Trans-lational Research, 10, 1228-1240. doi: 10.1007/s13346-019-00703-5 google scholar
41. Wirrell, E., Tinuper, P., Perucca, E., & Moshe, S.L. (2022). Introduc-tion to the epilepsy syndrome papers. Epilepsia, 63(6), 1330-1332. doi:10.1111/epi.17262 google scholar
42. Yi, Z.-M., Wen, C., Cai, T., Xu, L., Zhong, X.-L., . Zhai, S.-D. (2018). Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles. Neuropsychiatric Disease and Treatment, 15, 1-19. doi:10.2147/NDT.S181886 google scholar